Cy Biopharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

Cy Biopharma General Information

Description

Developer of a clinical-stage biotechnology-based platform designed to optimize psychedelics to generate new alternatives for chronic pain. The company's platform combines biochemical extracts with rarer serotonin receptor agonists to create new molecular entities with properties and operates analytical laboratories, enabling healthcare professionals to access non-opioid alternatives with demonstrated anti-inflammatory, neuroplastic, and psychological benefits to relieve chronic pain and treat rare diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Oberneuhofstrasse 6
  • 6340 Baar
  • Switzerland
+41 041
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Oberneuhofstrasse 6
  • 6340 Baar
  • Switzerland
+41 041

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cy Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 05-Aug-2026 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Cy Biopharma’s complete valuation and funding history, request access »

Cy Biopharma Patents

Cy Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025235784-A2 Ergoline derivatives and uses thereof Pending 08-May-2024
WO-2025235784-A3 Ergoline derivatives and uses thereof Pending 08-May-2024
WO-2025235800-A1 Ergoline derivatives and uses thereof Pending 08-May-2024
US-20260060994-A1 Glycosylated compositions and methods of use Pending 26-Aug-2022
EP-4577219-A1 Glycosylated psilocin derivatives and methods of use Pending 26-Aug-2022 A61K31/7056
To view Cy Biopharma’s complete patent history, request access »

Cy Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cy Biopharma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Social Impact Capital Venture Capital Minority
To view Cy Biopharma’s complete investors history, request access »

Cy Biopharma FAQs

  • When was Cy Biopharma founded?

    Cy Biopharma was founded in 2020.

  • Where is Cy Biopharma headquartered?

    Cy Biopharma is headquartered in Baar, Switzerland.

  • What is the size of Cy Biopharma?

    Cy Biopharma has 5 total employees.

  • What industry is Cy Biopharma in?

    Cy Biopharma’s primary industry is Drug Discovery.

  • Is Cy Biopharma a private or public company?

    Cy Biopharma is a Private company.

  • What is Cy Biopharma’s current revenue?

    The current revenue for Cy Biopharma is .

  • How much funding has Cy Biopharma raised over time?

    Cy Biopharma has raised $17.1M.

  • Who are Cy Biopharma’s investors?

    Social Impact Capital has invested in Cy Biopharma.

  • When was Cy Biopharma acquired?

    Cy Biopharma was acquired on 05-Aug-2026.

  • Who acquired Cy Biopharma?

    Cy Biopharma was acquired by Ensysce Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process